CONFIDENTIALITY AGREEMENTConfidentiality Agreement • June 30th, 2023 • ELI LILLY & Co • Pharmaceutical preparations
THIS CONFIDENTIALITY AGREEMENT (the “Agreement”) is made on the last date signed below, (the “Effective Date”), between Eli Lilly And Company, having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285, United States (“Lilly”), and DiCE Therapeutics, Inc. having its principal place of business at 400 East Jamie Court, Suite 300, South San Francisco, California, 94080, United States (“DiCE”).
FIRST AMENDMENT TO CONFIDENTIALITY AGREEMENTConfidentiality Agreement • June 30th, 2023 • ELI LILLY & Co • Pharmaceutical preparations
Eli Lilly And Company and DICE Therapeutics, Inc. entered into a Confidentiality Agreement effective April 21, 2022 (the “Agreement”). This amendment (“Amendment”) forms part of and is hereby incorporated by reference into the Agreement.
Offer to Purchase All Outstanding Shares of Common Stock of DICE THERAPEUTICS, INC. at $48.00 per share, net in cash, without interest and less any applicable tax withholding by DURNING ACQUISITION CORPORATION a wholly-owned subsidiary of ELI LILLY...Offer to Purchase • June 30th, 2023 • ELI LILLY & Co • Pharmaceutical preparations
Durning Acquisition Corporation, a Delaware corporation (“Purchaser”) and a wholly-owned subsidiary of Eli Lilly and Company, an Indiana corporation (“Lilly”), is offering to purchase all of the issued and outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of DICE Therapeutics, Inc., a Delaware corporation (“DICE”), at a purchase price of $48.00 per Share (the “Offer Price”), net to the stockholder in cash, without interest and less any applicable tax withholding, upon the terms and subject to the conditions set forth in this Offer to Purchase and in the related Letter of Transmittal (which, together with this Offer to Purchase, as each may be amended or supplemented from time to time, collectively constitute the “Offer”).
